MTVA icon

MetaVia (MTVA)

NASDAQ

$1.68

$0.57 (

+51.35%

)

1D
5D
1M
6M
1Y
5Y
Pre market

MTVA: $1.68 / ₿ 0 BTC / 2189 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$1.11
$0.97 - $19.03
$8.72M
1.76
$47,496,654.00
5.16M
$1.67 - $1.68
No

What is MetaVia (MTVA)?

MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. Vanoglipel (DA-1241) is a novel GPR119 (GPR119) agonist with development optionality as a standalone or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide-1 (GLP-1), glucagon-dependent insulinotropic polypeptide receptor (GIP), and peptide YY.

The MetaVia (MTVA) stock price has been rising

The MetaVia Inc. Common Stock (MTVA) stock pre-market price today is $1.68, reflecting a +51.35% pre-market move since the market last closed. The company’s market capitalization stands at $8.72M, with a daily trading volume of $47.50M shares. The previous closing price was $1.11.

Get started with MetaVia (MTVA)

Ready to get started? Follow the steps below, or read our guide on how to buy MetaVia stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy MTVA

Search for MTVA in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy MTVA.

MTVA FAQs

MTVA is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

MTVA is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, MetaVia Inc. Common Stock (MTVA) has traded between a low of $0.97 and a high of $19.03.

MTVA is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in MetaVia? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
MTVA icon
MTVA

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

AMST icon

AMST

RUBI icon

RUBI

ORGNW icon

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

BTMWW icon
ONCO icon

ONCO

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.